Skip to main content

Waldencast plc

corporate_fare Company Profile

Waldencast plc

WALD·NASDAQ·Industrial Applications And Services·CIK 0001840199

Waldencast plc operates as a beauty and wellness platform that develops, acquires, accelerates, and scales high-growth, purpose-driven brands. The company's business model is brand-led, aiming for customer proximity, business agility, and market responsiveness while preserving each brand's distinct identity. Waldencast's initial step in this strategy was the Business Combination with Obagi Medical and Milk Makeup. As part of the Waldencast platform, these brands benefit from the operational scale of a multi-brand platform, expertise in managing global beauty brands, a balanced portfolio designed to mitigate category fluctuations, asset-light efficiency, and the market responsiveness and speed of entrepreneurial independent brands. The company leases several properties for its operations. These include an office in London, United Kingdom, with 1,400 square feet expiring in December 2026; an office in Long Beach, California, with 28,300 square feet expiring in January 2027; an office in The Woodlands, Texas, with 16,500 square feet, where the sublease expired in December 2025 and is actively being marketed for sublease, expiring in January 2033; a subleased warehouse and office space in Conroe, Texas, totaling 35,000 square feet of warehouse space and 4,200 square feet of office space, running through February 2032; an office and in-house studio in New York, New York, with 17,500 square feet expiring in November 2030; and an office and in-house studio in Los Angeles, California, with 1,500 square feet, subleased on a month-to-month basis for a fee of $0.015 million per month. Waldencast has 3 executive officers and 364 full-time employees across the group. As of December 31, 2025, Obagi Medical had 248 non-unionized employees, and Milk Makeup had 100 non-unionized full-time employees.

Waldencast plc (NASDAQ:WALD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 10 items for WALD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-14, rated 9/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for WALD spans 6-K, 4, SCHEDULE 13D/A, 20-F.

Recent high-impact activity:

  • Waldencast to Voluntarily Delist from Nasdaq and Deregister — Last Trading Day Expected October 2
  • Director and 10% Owner Cristiano Souza Buys $505K of Waldencast Shares
  • Waldencast Finalizes Obagi Sale, Unveils Post-Transaction Financials and Leadership Reshuffle
  • Major Investor Liquidates Entire 7.5% Stake in Waldencast plc
  • FDA Approves Obagi Medical's saypha® ChIQ™ Injectable Hyaluronic Acid Gel

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$272.07M
Net Income
-$229.75M
Diluted EPS
-$2.01
Op. Cash Flow
-$12.82M
Free Cash Flow
-$16.25M
Gross Profit
$183.02M
Operating Income
-$217.54M
Cash & Equivalents
$30.38M
Total Debt
$136.52M
Debt / Equity
0.30×
Net Margin
-84.4%
Shares Outstanding
114.07M sh
Source: 20-F · filed 2026-03-13 · accession 0001840199-26-000019

Insider Transactions

WALD files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with W →
$1.11 -0.20% today
52-week range · as of 2026-09-14 $0.72 – $3.22
Market cap
$145.19M
Volume
1.6M (6.4× avg)
3-mo avg 244.7K
Live data · 2026-09-14 15:39 UTC · Market open

show_chartPrice Chart

Loading chart...

feed WALD - Latest Insights

WALD
Sep 14, 2026, 6:50 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.33
Real-time Price: $1.11 info
Change: -$0.2199 (-17%) info
Market Cap: $145.186M info
WALD
Sep 01, 2026, 4:10 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.38
Real-time Price: $1.11 info
Change: -$0.2699 (-20%) info
Market Cap: $145.186M info
WALD
Jul 30, 2026, 5:26 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.85
Real-time Price: $1.11 info
Change: -$0.7399 (-40%) info
Market Cap: $145.186M info
WALD
Jun 26, 2026, 4:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.51
Real-time Price: $1.11 info
Change: -$0.3999 (-26%) info
Market Cap: $145.186M info
WALD
Jun 15, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.87
Real-time Price: $1.11 info
Change: -$0.759 (-41%) info
Market Cap: $145.186M info
WALD
Jun 01, 2026, 9:52 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.45
Real-time Price: $1.11 info
Change: -$0.3399 (-23%) info
Market Cap: $145.186M info
WALD
Apr 28, 2026, 5:29 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.809749
Real-time Price: $1.11 info
Change: +$0.300351 (+37%) info
Market Cap: $145.186M info
WALD
Mar 13, 2026, 6:46 AM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $1.46
Real-time Price: $1.11 info
Change: -$0.3499 (-24%) info
Market Cap: $145.186M info
WALD
Mar 11, 2026, 4:16 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.52
Real-time Price: $1.11 info
Change: -$0.4099 (-27%) info
Market Cap: $145.186M info
WALD
Feb 27, 2026, 8:33 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.70
Real-time Price: $1.11 info
Change: -$0.5899 (-35%) info
Market Cap: $145.186M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets